Frost & Sullivan Lauds ClearFlow's ACT Technology As Transformational Force in Post-Operative Cardiothoracic Surgery Protocols
March 28, 2017
March 28, 2017
SANTA CLARA, Calif., March 28 -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
Based on its recent analysis of the retained blood syndrome solutions market, Frost & Sullivan recognizes ClearFlow, Inc. with the 2017 Global Frost & Sullivan Award for New Product Innovation. ClearFlow has disrupted post-operative cardiothoracic surgery ca . . .
Based on its recent analysis of the retained blood syndrome solutions market, Frost & Sullivan recognizes ClearFlow, Inc. with the 2017 Global Frost & Sullivan Award for New Product Innovation. ClearFlow has disrupted post-operative cardiothoracic surgery ca . . .